
Giving Cancer Survivors a Stronger Voice
More people are surviving cancer than ever before. But finishing treatment does not always mean the end of the cancer journey.
Life after treatment: the challenges and the gains
Many cancer survivors continue to experience challenges months or even years after treatment. These can include fatigue, pain, anxiety, difficulties returning to work, changes in relationships, or concerns about the future. At the same time, many people also describe positive changes, such as a greater appreciation of life, stronger personal relationships and increased resilience.
A new tool built for cancer survivors
Understanding these experiences is essential for improving survivorship care. To help achieve this, researchers from the EORTC Quality of Life Group (QLG) have developed a new questionnaire designed specifically for cancer survivors.
The questionnaire, called QLQ-SURV100, was created to better understand life after cancer treatment and to ensure that survivors’ experiences are reflected in research and care. Unlike questionnaires designed for patients receiving active treatment, it focuses on the issues that may affect people once treatment has ended.
The questionnaire was tested in a large international study involving nearly 1,500 cancer survivors from 46 centres in 21 countries. The results showed that it provides a reliable way to capture a wide range of experiences, including physical well-being, emotional health, daily activities, social relationships and the longer-term effects of cancer and its treatment.
Importantly, the questionnaire was developed with input from both survivors and healthcare professionals, helping to ensure that it reflects the issues people consider most important after treatment.
Why it matters for survivors, researchers and doctors
As the number of cancer survivors continues to grow worldwide, tools like the questionnaire can help researchers and healthcare professionals better understand survivors’ needs and identify areas where additional support may be required. They can also help ensure that the patient perspective remains an important part of clinical cancer research alongside traditional clinical outcomes.
The questionnaire is the result of years of work by the EORTC Quality of Life Group, an international network dedicated to ensuring that the experiences of patients and survivors are measured and understood throughout the cancer journey. By providing a common way to assess quality of life after cancer, the QLQ-SURV100 questionnaire has the potential to support research and care around the world.
Beyond survival
Ultimately, the goal is simple: to ensure that as more people live longer after cancer, greater attention is paid not only to survival, but also to quality of life.
Learn more about the work of the EORTC Quality of Life Group and how its research helps bring the patient voice into clinical cancer research and care.
You can also help support EORTC’s game-changing clinical research to unleash scientific breakthrough and transform cancer patients’ lives. Learn how to GET INVOLVED, or Make a Contribution Now.







Get Social